Effect of Hewei-Decoction on chronic atrophic gastritis and eradication of Helicobacter pylori

World Journal of Gastroenterology

Volumn 11, Issue 7, 2005, Pages 986-989

  Ji, Wan Sheng ^a   Gao, Zhi Xing ^a   Wu, Kai Chun ^b   Qui, Jun Wen ^b   Shi, Bing Long ^c   Fan, Dai Ming ^b  

^a WEIFANG MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^c Guangzhou Military Region   (China)

Author keywords

Chronic atrophic gastritis; Helicobacter pylori infection; Hewei Decoction

Indexed keywords

ANTIINFECTIVE AGENT; ATRACTYLODES EXTRACT; AURANTIIN; BUPLEURUM ROOT; CHINESE DRUG; COPTIS RHIZOME; CRATAEGUS EXTRACT; CYPERUS EXTRACT; DIOSCOREA EXTRACT; EVODIA FRUIT; GLYCYRRHIZA EXTRACT; HERBACEOUS AGENT; HEWEI DECOCTION; MAGNOLIA OFFICINALIS EXTRACT; PAEONIA EXTRACT; PINELLIA EXTRACT; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIBACTERIAL ACTIVITY; ARTICLE; CHRONIC GASTRITIS; CLINICAL FEATURE; CONTROLLED STUDY; CYPERUS; DIOSCOREACEAE; DISEASE CLASSIFICATION; DRUG EFFICACY; DRUG MECHANISM; DRUG RESPONSE; FEMALE; HELICOBACTER PYLORI; HUMAN; INFECTION CONTROL; MAGNOLIA OFFICINALIS; MAGNOLIACEAE; MAJOR CLINICAL STUDY; MALE; PINELLIA; SCORING SYSTEM; TREATMENT OUTCOME;

EID: 14844296978     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v11.i7.986     Document Type: Article

References (22)

1. Wang Y. Internal Medicine of Traditional Chinese Medicine. 1st ed. Shanghai: Shanghai Traditional Chinese Medicine University Publishing House, 2002: 136-144
2. Zheng XY. Guidelines for clinical studies on new Traditional Chinese Medical Drugs (Trial). 1st ed. Beijing: Chinese Medical Scientific and Technological Pub. 2002: 124-129
3. Zhou JZ. Chinese Integrative Medical standard for Diagnosis, Differentiation, and effect evaluation of chronic gastritis (Trial). J Chin Integr Med 1990; 10: 318-319
4. Layke JC, Lopez PP. Gastric cancer: Diagnosis and treatment options. Am Fam Physician 2004; 69: 1133-1140
5. Kato I, Vivas J, Plummer M, Lopez G, Peraza S, Castro D, Sanchez V, Cano E, Andrade O, Garcia R, Franceschi S, Oliver W, Munoz N. Environmental factors in Helicobacter pylori-related gastric precancerous lesions in Venezuela. Cancer Epidemiol Biomarkers Prev 2004; 13: 468-476
6. Yin GY, He XF, Yin YF. Study on mitochondrial ultrastructure, trace elements and correlative factors of gastric mucosa in patients with spleen deficiency syndrome. Zhongguo Zhongxiyi Jiehe Zazhi 1995; 15: 719-723
7. Ren H, Liu W, Niu L, Lu G, Lu Y. Comparative observations on the types of atrophic gastritis and biopsy pathology of gastric mucosa. J Tradit Chin Med 1994; 14: 303-307
8. Ke X, Wu YM, Yang CB. Deficiency and excess syndrome of chronic atrophic gastritis. Zhongguo Zhongxiyi Jiehe Zazhi 1993; 13: 600-607
9. Ren HY, Chen GX, Niu LD. Pathomorphologic changes on 150 chronic atrophic gastritis patients by treatment based on syndrome differentiation. Zhongguo Zhongxiyi Jiehe Zazhi 1993; 13: 144-146
10. Ren HY, Niu LD. Histopathology of spleen deficiency syndrome of chronic atrophic gastritis and its ultrastructural changes. Zhongguo Zhongxiyi Jiehe Zazhi 1992; 12: 593-597
11. Meng M. TCM differential treatment of 57 cases of chronic gastritis complicated by ulcerative colitis. J Tradit Chin Med 1999; 19: 10-15
12. Zhang ZM, Yu YT. Treatment of chronic gastritis with traditional Chinese medicine-yingwei tablet. Zhongguo Zhongxiyi Jiehe Zazhi 1992; 12: 598-601
13. Xie QS. 47 cases of chronic atrophic gastritis treated with the modality of depressing the upward adverse flow of qi. J Tradit Chin Med 1989; 9: 285-286
14. Chen KJ, Chen K. Achievements in clinical research of treating internal diseases with traditional Chinese medicine in recent years. Chin Med J 1989; 102: 735-739
15. Wei BH. Clinical and experimental study on the prescription of jianpi yipi. Zhongxiyi Jiehe Zazhi 1989;9: 537-539
16. Xue FB, Xu YY, Wan Y, Pan BR, Ren J, Fan DM. Association of H pylori infection with gastric carcinoma: A Meta analysis. World J Gastroenterol 2001; 7: 801-804
17. Wright J, Manning AP, Bolus J, Rajaratnam G. Do all patients in primary care who may benefit from eradication of Helicobacter pylori have access to effective care? Public Health 2001; 115: 282-285
18. O'Connor HJ, O'Morain CA. Helicobacter pylori and gastroesophageal reflux disease: To treat or not to treat? Scand J Gastroenterol 2001; 36: 677-682
19. Anderson J, Gonzalez J. H pylori infection. Review of the guideline for diagnosis and treatment. Geriatrics 2000; 55: 44-49
20. Gold BD. Current therapy for Helicobacter pylori infection in children and adolescents. Can J Gastroenterol 1999; 13: 571-579
21. Iacopini F, Consolazio A, Bosco D, Marcheggiano A, Bella A, Pica R, Paoluzi OA, Crispino P, Rivera M, Mottolese M, Nardi F, Paoluzi P. Oxidative damage of the gastric mucosa in Helicobacter pylori positive chronic atrophic and nonatrophic gastritis, before and after eradication. Helicobacter 2003; 8: 503-512
22. +-adenosine triphosphatase in human gastric autoimmunity. J Exp Med 2003; 198: 1147-1156